PSY News and Press, Defiance Next Gen Altered Experience ETF

Summary The Green Giants portfolio fell by -12.38% for the quarter - July and August were bright spots. Political progress is the biggest near-term driver of prices: all eyes are on SAFE Banking. The new narrative is that the combination of inflation, falling cannabis prices, ...

Banking legislation push is getting a lot of buzz. SAFE passage would be a game changer for valuations with large MSOs disproportionately benefitting with initial stock gains. Within that group, believe Ascend and AYR should be considered for near-term investment. Both are as well...

The Board of Trustees of ETF Series Solutions, upon a recommendation from Defiance ETFs, LLC, the investment adviser to the Defiance Next Gen Altered Experience ETF, and the Defiance Next Gen SPAC Derived ETF (each, a “Fund” and collectively, the “Funds”), ...

On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan's 2018 book, "How to Change Your Mind," is one of Netflix's most-watched shows. ...

The Green Giants portfolio lagged benchmarks this month. The biggest drop came when SAFE Banking was once again removed by the senate and not included in the America Competes Act. Investors I speak with remain interested in cannabis but are discouraged by the price action. ...

Renewed interest in psychedelics in both public and scientific spaces has increased investor interest in psychedelic stocks. The psychedelic market is projected to achieve a valuation of $10.7 billion by 2027 , and investors are looking to cash in on the industry before it is satura...

The Green Giants portfolio fared better than the industry benchmarks and is now besting MSOS and YOLO by about 10% year-to-date. New Jersey is the most meaningful new market in 2022 and more stores and bigger grows will add much-needed revenue in the next couple of quarters. In an...

The S&P 500 is off to its worst start since 1939, and the NASDAQ notched its worst opening quarter since launching in 1971. For cannabis stocks, it was the worst month since COVID-lows of March 2020. April was another month where equity markets sold off, and cannabis got hit harde...

March was a mixed month for cannabis stocks. Cresco's deal to acquire Columbia Care provides an increasingly important scale and is expected to create the largest MSO based on pro-forma revenue. The market is pricing in zero political progress, endless state setbacks, and ignoring...

All signs point towards an imminent withdrawal of central bank stimulus, globally. Meanwhile, the U.S. economy is headed for one of the largest fiscal cliffs ever. Global growth is slowing even before massive stimulus withdrawal. For further details see: Prepare For Turb...